Nuclide Therapeutics Ltd
Research and experimental development on biotechnology · London
ActiveUnited KingdomIncorporated 2024Private Limited Company
Ownership evidence
Reported ownership and control rights in this business, with source dates.
Reported ownership & control
0 without an end date · 2 ceasedNo control records without an end date are available. This alone does not establish who owns or controls the company.
Show 2 ceased records
RE
Dr Richard Sherburne EdwardsIndividual
Shares: over 25%, up to 50%Voting rights: over 25%, up to 50%Right to appoint or remove directors
Notified 2024-05-22 · Ceased 2024-06-13
Source record 240849973TW
Dr Timothy Howard WitneyIndividual
Shares: over 25%, up to 50%Voting rights: over 25%, up to 50%Right to appoint or remove directors
Notified 2024-05-22 · Ceased 2024-06-13
Source record 240849974People behind the business
Current appointments and the wider business interests of each person.
Appointments
5 current · 0 historicalMU
Matthias UnitzCurrent director
Appointed 2025-07-31 · 1 yr · Investor Director
MT
Muhammet TancCurrent director
Appointed 2024-06-13 · 2 yrs · Scientist
SD
Sofia Dos SantosCurrent director
Appointed 2024-06-13 · 2 yrs · Scientist
TW
Timothy WitneyCurrent director
Appointed 2024-05-22 · 2 yrs · Scientist
RE
Richard EdwardsCurrent director
Appointed 2024-05-22 · 2 yrs · Scientist
Board profile
- People with appointments
- 5
- Directors assessed
- 5
- Median age
- 41
- Under 35
- 0
- 65 and over
- 0
- Disqualified match
- None active